The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Oral Flecainide Acetate for the Treatment of Ventricular Arrhythmias
Abstract
The antiarrhythmic efficacy and safety of oral flecainide acetate were assessed during a controlled, short-term dosage-maintenance study. Thirteen patients with chronic ventricular ectopy entered a placebo control period, and 11 with persistent, frequent (greater than 600 per 12 hours) premature ventricular complexes (PVCs) advanced to drug therapy. Of 10 patients completing a trial of different doses, nine responded completely, with a mean PVC suppression of 98,3 per cent. Repetitive PVCs were eliminated. The mean effective dose was 189 mg per 12 hours, and the effective plasma concentration before administration of a dose averaged 635 ng per milliliter. One patient responded partially (68 per cent of PVCs suppressed). Flecainide continued to be effective and well tolerated at the end of a two-week outpatient trial in the nine complete responders, maintaining an average PVC suppression of 94.6 per cent. The PR and QRS intervals were mildly prolonged. The echocardiographic ejection fraction was unchanged during treatment. The elimination half-life was long - 18.8 +/- 3.8 hours. Flecainide thus appears to be a highly effective and well-tolerated antiarrhythmic agent with favorable pharmacokinetics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudden cardiac death: The major challenge confronting contemporary cardiology
Lown, B. (1979) · The American Journal of Cardiology · doi:10.1016/s0002-9149(79)80021-1 · Cited by 451
Cited by
Polymorphism of human cytochrome P450 enzymes and its clinical impact
Zhou, S.-F., Liu, J.-P., & Chowbay, B. (2009) · Drug Metabolism Reviews · doi:10.1080/03602530902843483 · Cited by 826
Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance: Part I
Zhou, S.-F. (2009) · Clinical Pharmacokinetics · doi:10.2165/11318030-000000000-00000 · Cited by 756
Anderson, J. L., Gilbert, E. M., Alpert, B. L., Henthorn, R. W., Waldo, A. L., Bhandari, A. K., Hawkinson, R. W., & Pritchett, E. L. (1989) · Circulation · doi:10.1161/01.cir.80.6.1557 · Cited by 287
Self-citationSuttorp, M. J., Kingma, J. H., Jessurun, E. R., Lie-A-Huen, L., Van Hemel, N. M., & Lie, K. I. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90326-k · Cited by 282
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
Tamargo, J., Le Heuzey, J.-Y., & Mabo, P. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1832-0 · Cited by 276
Metadata
- Authors
- Anderson, J. L., Stewart, J. R., Perry, B. A., Van Hamersveld, D. D., Johnson, T. A., Conard, G. J., Chang, S. F., Kvam, D. C., & Pitt, B.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1981-08-27
- Volume
- 305
- Issue
- 9
- Pages
- 473-477
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2325395722
- Cited by
- 222
- References
- 1
- FWCI
- 18.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Oral Flecainide Acetate for the Treatment of Ventricular Arrhythmias. https://app.cochat.ai/papers/10.1056/nejm198108273050901
- The paper
- Anderson, J. L., Stewart, J. R., Perry, B. A., Van Hamersveld, D. D., Johnson, T. A., Conard, G. J., Chang, S. F., Kvam, D. C., & Pitt, B. (1981). Oral Flecainide Acetate for the Treatment of Ventricular Arrhythmias. New England Journal of Medicine. https://doi.org/10.1056/nejm198108273050901
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.